[CLSTR]
< Back to situations

[ORGANIZATION]

Istituto Nazionale dei Tumori

Featured in 12 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT] [US]

Barriers to rare cancer treatment and research

2 clusters · 4 sources · last updated

Latest: Medical experts highlight gaps in rare tumor and adolescent cancer care

Medical experts and advocacy groups are identifying systemic barriers to treatment and research for rare cancers and vulnerable patient populations. In the United States, insurance coverage gaps have been highlighted by

[ACTIVE] [BUSINESS] [US] [CN] [ES]

Moderna and Merck melanoma vaccine clinical trials

16 clusters · 450 sources · last updated

Latest: Moderna expands cancer therapy ties and benefits from vaccine program news

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

[ACTIVE] [HEALTH] [IT]

Advancements in Italian oncology and radiotherapy

4 clusters · 34 sources · last updated

Latest: Italy advances leukemia treatment through immunotherapy and integrated care models

Italian medical institutions continue to advance oncology through specialized training, genomic profiling, and personalized care models. To support genomic cancer profiling for approximately 15,000 eligible patients annu

[QUIET] [CULTURE] [IT]

AIL Milano Monza Brianza 50th anniversary

3 clusters · 17 sources · last updated

Latest: AIL Milano Monza Brianza marks 50 years of patient support

AIL Milano Monza Brianza is commemorating 50 years of service dedicated to patients and research in oncological-hematological diseases. To mark this milestone, the association organized a reflection event in Milan on Oct

[QUIET] [HEALTH] [IT]

Milan healthcare leadership and protocol updates

2 clusters · 4 sources · last updated

Latest: Niguarda Hospital leadership transition announced in Milan

Healthcare developments in the Milan region have involved both clinical protocol updates and leadership transitions. In early September, new medical leadership was announced for the Obstetrics and Gynecology complex at

[QUIET] [HEALTH] [IT]

Eplontersen trials and Italian healthcare advancements

2 clusters · 90 sources · last updated

Latest: Italy advances healthcare through infrastructure and medical innovation

Clinical developments regarding the drug eplontersen have shown divergent results depending on the specific condition being treated. In the phase 3 CARDIO-TTRansform trial, eplontersen failed to significantly reduce card

Also covered in